Sold Alan James Group assets of its subsidiary AJG Brands, Inc. In July, the Company executed an agreement to sell the Alan James Group assets of its subsidiary AJG Brands, Inc. to Pep Products, Inc. for $4.6 million. Launched Inherent Health Brand of Genetic Tests. Announced in June the introduction of Inherent Health brand of genetic tests and related programs including the first-of-its-kind test for weight management that identifies an individual's genetic tendencies for weight gain and metabolism.Granted License of Heart Health Genetic Test to LABEC Pharma. In April, the Company entered into a licensing agreement to permit LABEC Pharma to market and sell the Company's Heart Health genetic test throughout Spain and Portugal. Amex Accepts Plan to Meet Continued Listing Standards. In May, Interleukin Genetics announced the Corporate Compliance Staff of the NYSE Amex LLC (the "Exchange") accepted the Company's plan to meet continued listing standards and granted the Company an extension to become compliant through December 31, 2009.

Scientific Highlights

Presented Data at the American Diabetes Association's Annual Meeting. In June, Interleukin Genetics presented research findings highlighting associations between perilipin gene variants and response to weight loss in overweight individuals at the ADA's 69(th) Scientific Sessions in New Orleans. Co-Presented on Use of Biomarkers in Drug Development at BIO. Moderated and co-presented panel discussion on use of biomarkers in drug development in May at the BIO International Convention.

www.ilgenetics